Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Countdown (formerly Countdown for a Cure) is a global non-traditional nonprofit organization dedicated to accelerating mitochondrial science and medicine to transform how we prevent disease, extend healthspan, and treat chronic conditions. Founded by Mitzi Solomon, the organization funds bold, high-risk, high-reward research across six core pillars, including women's health, early detection, chronic disease, and frontier therapeutics. Countdown actively supports breakthrough projects such as mitochondrial transplantation for Duchenne muscular dystrophy and muscle preservation. By uniting scientists, clinicians, philanthropists, and consumer brands, Countdown aims to bring cellular energy to the center of human health and modern medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Countdown.